Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
2017 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
Einsele, H.; Engelhardt, M.; Tapprich, C.; Müller, J.; Liebisch, P.; Langer, C. & Kropff, M. et al. (2017)
British Journal of Haematology, 179(4) pp. 586-597. DOI: https://doi.org/10.1111/bjh.14920
Documents & Media
Details
- Authors
- Einsele, Hermann; Engelhardt, Monika; Tapprich, Christoph; Müller, Jürgen; Liebisch, Peter; Langer, Christian; Kropff, Martin; Mügge, Lars O.; Jung, Wolfram ; Wolf, Hans-Heinrich; Metzner, Bernd; Hart, Christina; Gramatzki, Martin; Hertenstein, Bernd; Pfreundschuh, Michael; Rösler, Wolf; Fischer, Thomas; Maschmeyer, Georg; Kanz, Lothar; Hess, Georg; Jäger, Elke; Bentz, Martin; Dürk, Heinz A.; Salwender, Hans; Hebart, Holger; Straka, Christian; Knop, Stefan
- Issue Date
- 2017
- Journal
- British Journal of Haematology
- ISSN
- 0007-1048
- Language
- English
